A prophylactic cream, ointment or deodorant for the prevention of the formation of yeast infections.

An application of a series of compounds in controlling or killing mites. It has been found by comparison that the compounds, when compared with a control group, can reduce the survival time of mites; in particular, taraxerol, diosmetin, and taraxasteryl acetate can significantly shorten the survival time of mites, and can be used for miticide and mite control products (such as drugs, cosmetic products, daily products and so on).

The present invention relates to a process for dyeing keratin fibres, in particular human keratin fibres such as the hair, in which said fibres are treated using one or more cosmetic compositions comprising a) one or more dyes chosen from synthetic direct dyes and dyes of natural origin, b) one or more titanium salts and b1) optionally one or more particular carboxylic acids, c) one or more cellulose-based polysaccharides, d) optionally one or more organic compounds that are liquid at 25° C., with a Hansen solubility parameter value δH<16 (MPa).sup.1/2 at 25° C., e) optionally one or more chemical oxidizing agents such as hydrogen peroxide or one or more hydrogen peroxide-generating systems.

The invention relates to multi-action dermatological compositions that provides lightening, protecting and anti-aging effects to the skin of a user. The composition comprises niacinamide, arbutin, tranexamic acid, ubiquinone, a DHEA-like component, curcuma oily extract and marine exopolysaccharides. The invention also relates to methods of dermatological treatment and a method of treating hyperpigmentation by applying the composition to the skin of a user.

A method for screening compounds and compositions that reduce cetyl pyridinium chloride activation of TRPA1 receptor or TRPV1 receptor.

Disclosed is a composition comprising, in an aqueous phase: a) at least one ether of formula (I): R—O—R′ in which R and R′, which may be identical or different, denotes a linear or branched C.sub.6-C.sub.25 alkyl or alkenyl radical, R and R′ being chosen such that the ether is liquid at a temperature of less than or equal to 30° C.; b) at least one surfactant chosen from anionic surfactant, amphoteric or zwitterionic surfactant, or a mixture thereof; c) at least one cationic alkyldiallylamine or dialkyldiallylammonium cyclopolymer; and d) soybean oil.

Provided is a composition comprising, in an aqueous phase at least one anionic surfactant, at least one amphoteric and/or zwitterionic surfactant, at least one alkyl(poly)glycoside nonionic surfactant, at least on polymer chosen from cationic polymers of cationic cellulose, cationic alkyldiallylamine or dialkyldiallylammonium cyclopolymer, amphoteric polymers which comprising one or more units derived from a monomer of (meth)acrylate or (meth)acrylamide type, a monomer of (meth)acrylamidoalkyltrialkylammonium type, or a monomer of (meth)acrylic type, or a mixture thereof, and at least on fatty acid ester of glycerol and/or of polyglycerol.

The present invention discloses a use of neohesperidin or a neohesperidin-containing plant extract in the manufacture of a product for improving and/or promoting skin microcirculation, or for eliminating and/or alleviating diseases or conditions associated with poor skin microcirculation. The present invention also discloses a composition comprising an effective amount of neohesperidin or a neohesperidin-containing plant extract, and to a method for improving and/or promoting skin microcirculation, or eliminating and/or alleviating diseases or conditions associated with poor skin microcirculation, by using neohesperidin. The skin microcirculation of the present invention is preferably eye skin microcirculation.

The present invention provides a skin barrier function-improving agent including an inositol derivative as an active ingredient in which inositol and saccharide are bonded, and a composition for improving a skin barrier function including the above skin barrier function-improving agent and a pharmacologically acceptable carrier.

Disclosed is a method for reducing the appearance of cellulite, improving the texture of skin, or reducing the appearance of a fine line or wrinkle in skin that has cellulite, rough skin texture, or a fine line or wrinkle, the method comprising topically applying a composition to the skin that includes effective amounts of caffeine, escin, and an extract from Ascophyllum nodosum, wherein topical application of the composition reduces the appearance of cellulite, improves the texture of the skin, or reduces the appearance of the fine line or wrinkle.